FDA on confusing drug names and the Second Circuits on rogue science

Five pharma litigation hot topics in three minutes

United States Video January 2021 03:46

Video Details

This week, Jan Dodd, a partner in Los Angeles whose practice focuses on advising pharmaceutical, medical device, and manufacturing companies on product liability lawsuits and risk mitigation, discusses:

  • FDA guidance
  • Drug pricing
  • Daubert
  • Securities class action
  • Did you know?